Challenges in the classification of atrial fibrillation

The incidence and prevalence of atrial fibrillation (AF) are increasing worldwide. AF is of public health importance because it accounts for substantial morbidity, mortality, and health-care costs. AF may be transient initially, but many patients have progressive disease marked by increasing frequency and duration of episodes. Various classification schemes for AF have been proposed, although current guidelines are based on temporal rhythm-based patterns. We discuss existing schemes for the classification of AF, focusing on the advantages and limitations of the pattern-based scheme, in the context of new knowledge about AF pathophysiology, AF patterns, and clinical outcomes. Furthermore, we address gaps in knowledge that present opportunities to re-examine the current pattern-based classification of AF. A future classification scheme should ideally combine elements such as the risk of stroke, an assessment of symptoms, and the degree of impairment of the atrial substrate.

[1]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[2]  V. Fuster,et al.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation , 2001 .

[3]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[4]  A. Capucci,et al.  Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events , 2009, Journal of cardiovascular electrophysiology.

[5]  P. Vestergaard,et al.  Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. , 2005, International journal of cardiology.

[6]  P. Petersen,et al.  Embolic complications in paroxysmal atrial fibrillation. , 1986, Stroke.

[7]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[8]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[9]  G. Breithardt,et al.  The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[11]  D. Henrion,et al.  A 5-year prospective follow-up study in essential cryofibrinogenemia patients. , 2011, Autoimmunity reviews.

[12]  Eric Boerwinkle,et al.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.

[13]  V. Santinelli,et al.  Atrial fibrillation progression and management: a 5-year prospective follow-up study. , 2008, Heart rhythm.

[14]  Frédéric Costes,et al.  Frequent and Prolonged Asymptomatic Episodes of Paroxysmal Atrial Fibrillation Revealed by Automatic Long‐Term Event Recorders in Patients with a Negative 24‐Hour Holter , 2002, Pacing and clinical electrophysiology : PACE.

[15]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[16]  W. W. Brabham Valsartan for Prevention of Recurrent Atrial Fibrillation , 2010 .

[17]  Samuel Wann,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ , 2006, European heart journal.

[18]  B. Gersh,et al.  Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study , 2007, Circulation.

[19]  S. Lévy,et al.  Classification system of atrial fibrillation. , 2000, Current opinion in cardiology.

[20]  Ramon Brugada,et al.  Short QT Syndrome and Atrial Fibrillation Caused by Mutation in KCNH2 , 2005, Journal of cardiovascular electrophysiology.

[21]  R. Erbel,et al.  Prediction of Conversion from Paroxysmal to Permanent Atrial Fibrillation , 2007, Pacing and clinical electrophysiology : PACE.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  John V. Wylie,et al.  Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. , 2008, Archives of internal medicine.

[24]  P. Schauerte,et al.  Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[25]  G. Lip,et al.  Depression, anxiety, and quality of life in patients with atrial fibrillation. , 2007, Chest.

[26]  S. Nattel New ideas about atrial fibrillation 50 years on , 2002, Nature.

[27]  M. Pathy,et al.  Atrial fibrillation and stroke in elderly hospitalized patients. , 1986, Age and ageing.

[28]  E L Pritchett,et al.  Observations on the transition from intermittent to permanent atrial fibrillation. , 2000, American heart journal.

[29]  C. K. Madsen A 30-Year Follow-Up Study of Actual Applied Music Practice versus Estimated Practice , 2004 .

[30]  P Coumel,et al.  Paroxysmal atrial fibrillation: a disorder of autonomic tone? , 1994, European heart journal.

[31]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[32]  A. Camm,et al.  Classification of Atrial Fibrillation , 1997, The American journal of cardiology.

[33]  S. Lévy,et al.  Paroxysmal atrial fibrillation: a need for classification. , 1995, Journal of cardiovascular electrophysiology.

[34]  J. Halperin,et al.  Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.

[35]  D. Singer,et al.  Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[36]  R B D'Agostino,et al.  Impact of atrial fibrillation on mortality, stroke, and medical costs. , 1998, Archives of internal medicine.

[37]  R. Bubien,et al.  Quality of life in patients with atrial fibrillation. , 1996, Cardiology clinics.

[38]  Konomi Sakata,et al.  Usefulness of P-wave dispersion in standard twelve-lead electrocardiography to predict transition from paroxysmal to persistent atrial fibrillation. , 2008, The American journal of cardiology.

[39]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[40]  J. Ruskin,et al.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.

[41]  A. Raviele,et al.  Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials. , 2008, Journal of atrial fibrillation.

[42]  Silvia G Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit , 2006, Journal of the American College of Cardiology.

[43]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[44]  Massimo Santini,et al.  Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. , 2008, European heart journal.

[45]  R. Page,et al.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. , 1994, Circulation.

[46]  J. Halperin,et al.  Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1995, The American journal of cardiology.

[47]  S. Saksena,et al.  Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. , 2007, American heart journal.

[48]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[49]  Michael R. Rosen,et al.  Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.

[50]  J. Sage,et al.  Risk of recurrent stroke in patients with atrial fibrillation and non‐valvular heart disease. , 1983, Stroke.

[51]  Steven Swiryn,et al.  Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics. , 2004, Heart rhythm.

[52]  S. Lévy,et al.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.

[53]  G. Lip,et al.  Quality of life in older people with atrial fibrillation , 2009, Journal of Interventional Cardiac Electrophysiology.

[54]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[55]  Walter E. Garrey THE NATURE OF FIBRILLARY CONTRACTION OF THE HEART.—ITS RELATION TO TISSUE MASS AND FORM , 1914 .

[56]  G. Lamas,et al.  Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective , 2008, Journal of medical economics.

[57]  P. Zimetbaum,et al.  Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of Interventions , 2008, Journal of cardiovascular electrophysiology.

[58]  Salim Yusuf,et al.  Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. , 2007, Journal of the American College of Cardiology.

[59]  A. Skanes,et al.  A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. , 2006, The Canadian journal of cardiology.

[60]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[61]  David O. Martin,et al.  Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. , 2009, Heart rhythm.

[62]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[63]  G. Lip,et al.  Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. , 2001, European heart journal.

[64]  G. Lip,et al.  A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[65]  S Capewell,et al.  Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996. , 2001, European heart journal.

[66]  D. Todd,et al.  Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation , 2004, Circulation.

[67]  M. Rosenqvist,et al.  Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). , 2007, European heart journal.

[68]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[69]  N. Kouchoukos,et al.  Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery * , 1978, Pacing and clinical electrophysiology : PACE.

[70]  Denis Roy,et al.  Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. , 1986, American heart journal.

[71]  M. Wallander,et al.  Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK , 2005, BMC cardiovascular disorders.

[72]  T. Savides,et al.  Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. , 1989, The American journal of cardiology.

[73]  L. Fauchier,et al.  Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. , 2008, Journal of the American College of Cardiology.

[74]  Matthew Reynolds,et al.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[75]  E. Maltezos,et al.  Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[76]  G. Lip,et al.  Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. , 2007, Chest.

[77]  G. Lip,et al.  Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. , 2009, Journal of psychosomatic research.

[78]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[79]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[80]  C. Israel,et al.  Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.

[81]  Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation , 2008, Stroke.

[82]  F. Morady,et al.  Prevalence and Characteristics of Continuous Electrical Activity in Patients with Paroxysmal and Persistent Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.

[83]  J. Seward,et al.  Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. , 2008, European heart journal.

[84]  B. Gersh,et al.  The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[85]  F. Humar,et al.  Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. , 1999, American heart journal.

[86]  Gregory Y H Lip,et al.  Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.

[87]  M. Rosenqvist,et al.  Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. , 2010, European heart journal.

[88]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[89]  A R Feinstein,et al.  Risk for systemic embolization of atrial fibrillation without mitral stenosis. , 1990, The American journal of cardiology.

[90]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[91]  F. Gaita,et al.  Different patterns of atrial activation in idiopathic atrial fibrillation: simultaneous multisite atrial mapping in patients with paroxysmal and chronic atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[92]  R B D'Agostino,et al.  Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.

[93]  P. Gates,et al.  Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. , 1988, Stroke.

[94]  S. Lévy,et al.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.

[95]  S. Connolly,et al.  Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. , 2005, American Heart Journal.

[96]  Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence. , 1995, Coronary artery disease.

[97]  A. Laupacis,et al.  Population rates of hospitalization for atrial fibrillation/flutter in Canada. , 2004, The Canadian journal of cardiology.

[98]  Robby Nieuwlaat,et al.  Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. , 2010, Journal of the American College of Cardiology.

[99]  Samuel Wann,et al.  [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[100]  D. Singer,et al.  Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. , 1991, The American journal of medicine.

[101]  J. Nerbonne,et al.  Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.

[102]  T. Yamashita,et al.  Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[103]  S. Mouly,et al.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2007, The Cochrane database of systematic reviews.

[104]  J Fujii,et al.  Clinical features of paroxysmal atrial fibrillation. An observation of 94 patients. , 1981, Japanese heart journal.

[105]  M. Gollob,et al.  Impact of genetic discoveries on the classification of lone atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[106]  James B Seward,et al.  The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. , 2003, Journal of the American College of Cardiology.

[107]  C. Gieger,et al.  A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.

[108]  S. Saksena,et al.  Relationship between atrial tachyarrhythmias and symptoms. , 2005, Heart rhythm.

[109]  A. Skanes,et al.  Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale , 2009, Circulation. Arrhythmia and electrophysiology.

[110]  J. Agmon,et al.  Diagnosis and characteristics of lone atrial fibrillation. , 1989, Chest.

[111]  B. Gersh,et al.  Effect of atrial fibrillation pattern on survival in a community-based cohort. , 2005, The American journal of cardiology.

[112]  J. Halperin,et al.  Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1995, The American journal of cardiology.